Association of the redesigned Comprehensive Care for Joint Replacement model with racial/ethnic and socioeconomic disparities in joint replacement surgeries

重新设计的关节置换综合护理模式与关节置换手术中种族/民族和社会经济差异的关联

基本信息

  • 批准号:
    10711959
  • 负责人:
  • 金额:
    $ 35.76万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2023
  • 资助国家:
    美国
  • 起止时间:
    2023-07-13 至 2027-01-31
  • 项目状态:
    未结题

项目摘要

ABSTRACT Total hip and knee replacements (“total joint replacements” [TJRs]) are highly successful surgeries for patients with end-stage arthritis. Despite their clinical benefits, racial/ethnic and socioeconomic disparities in the use and outcomes of these surgeries are well-established. These disparities have persisted for decades despite well-intentioned and effective disparity reduction strategies that have been locally implemented. In the absence of a national reform that incentivizes disparity reduction, the vision of achieving TJR equity may remain unfulfilled. Medicare’s 2016 Comprehensive Care for Joint Replacement (CJR) model is a bundled payment reform aimed at improving quality and reducing spending for Medicare beneficiaries undergoing TJRs. In 2021, the CJR was redesigned (rCJR) to include adjustments for social risk (dual-eligibility for Medicare and Medicaid) and clinical risk (hierarchical condition category score and age) – measures that could potentially reduce TJR disparities by ‘recognizing’ the higher spending for marginalized patients (many of whom belong to racial/ethnic minority or lower socioeconomic groups, and are in poorer health). These adjustments are likely to reduce incentives for hospitals to avoid operating on marginalized patients, provide these patients access to high-quality hospitals, and increase quality/price competition between hospitals to attract these patients; thereby promoting equity in TJR use and postoperative outcomes. In theory, the new risk adjustment measures could potentially transform the rCJR into a national TJR disparity reduction strategy. However, there is little empirical evidence to support our hypothesis. Thus, our objective is to evaluate rCJR’s association with racial/ethnic and socioeconomic disparities in TJR use, outcomes, and spending, with a focus on the performance of safety-net hospitals. We will use national Medicare data from 2018-2024 to evaluate rCJR’s association with disparities in the use of TJRs (Aim 1) and in clinical metrics (Aim 2). We will also examine whether the rCJR may have influenced TJR spending for marginalized patients (Aim 3). Our work is significant because we will answer questions such as whether the rCJR was effective in reducing disparities, which metrics were most influenced by the rCJR, and which institutions successfully reduced disparities. These findings are critical for understanding whether and how the rCJR can be leveraged to reduce disparities nationally, and for realizing the elusive target of equity in TJR care for patients with arthritis.
摘要 全髋关节和膝关节置换术(“全关节置换术”[TJR])是非常成功的手术, 终末期关节炎患者。尽管它们具有临床益处,但种族/民族和社会经济差异仍然存在。 这些手术的使用和结果是公认的。这些差距已经持续了几十年 尽管在当地实施了善意和有效的减少差距战略。在 如果没有一个国家改革,激励减少差距,实现TJR公平的愿景可能 仍然没有实现。Medicare的2016年关节置换综合护理(CJR)模型是一个捆绑式的 支付改革旨在提高质量和减少医疗保险受益人的支出, TJR。2021年,CJR被重新设计(rCJR),以包括社会风险调整(双重资格) 医疗保险和医疗补助)和临床风险(分层条件类别评分和年龄)-可以 通过“认识到”边缘化患者的更高支出(许多 属于少数种族/族裔或社会经济地位较低的群体,健康状况较差)。这些 调整可能会减少医院避免对边缘化患者进行手术的激励, 这些患者获得高质量的医院,并增加医院之间的质量/价格竞争, 吸引这些患者;从而促进TJR使用和术后结局的公平性。理论上,新的风险 调整措施可能会将rCJR转变为国家TJR差距缩小战略。 然而,几乎没有经验证据支持我们的假设。因此,我们的目标是评估rCJR的 与TJR使用、结果和支出中的种族/民族和社会经济差异相关,重点是 安全网医院的表现。我们将使用2018-2024年的国家医疗保险数据来评估 rCJR与TJR使用差异(目标1)和临床指标(目标2)的相关性。我们还将 研究是否rCJR可能会影响边缘化患者的TJR支出(目的3)。我们的工作是 重要的是,我们将回答诸如rCJR是否有效地减少了差异, 哪些指标受rCJR影响最大,哪些机构成功地减少了差异。这些 研究结果对于理解是否以及如何利用rCJR来减少差异至关重要 在全国范围内,并实现关节炎患者TJR护理公平的难以捉摸的目标。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Caroline Pinto Thirukumaran其他文献

Caroline Pinto Thirukumaran的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Caroline Pinto Thirukumaran', 18)}}的其他基金

Racial Disparities in Analgesic Prescribing for Post-Surgical Pain Management among Older Americans following Hip and Knee Replacement Surgeries
美国老年人髋关节和膝关节置换手术后术后疼痛管理镇痛处方的种族差异
  • 批准号:
    10508187
  • 财政年份:
    2022
  • 资助金额:
    $ 35.76万
  • 项目类别:
Racial Disparities in Analgesic Prescribing for Post-Surgical Pain Management among Older Americans following Hip and Knee Replacement Surgeries
美国老年人髋关节和膝关节置换手术后术后疼痛管理镇痛处方的种族差异
  • 批准号:
    10693957
  • 财政年份:
    2022
  • 资助金额:
    $ 35.76万
  • 项目类别:
Impact of Bundled Payment Reforms on Racial and Socioeconomic Disparities in Hip and Knee Replacement Surgeries
捆绑支付改革对髋关节和膝关节置换手术中种族和社会经济差异的影响
  • 批准号:
    9468901
  • 财政年份:
    2017
  • 资助金额:
    $ 35.76万
  • 项目类别:
Impact of Bundled Payment Reforms on Racial and Socioeconomic Disparities in Hip and Knee Replacement Surgeries
捆绑支付改革对髋关节和膝关节置换手术中种族和社会经济差异的影响
  • 批准号:
    9899752
  • 财政年份:
    2017
  • 资助金额:
    $ 35.76万
  • 项目类别:
Impact of Bundled Payment Reforms on Racial and Socioeconomic Disparities in Hip and Knee Replacement Surgeries
捆绑支付改革对髋关节和膝关节置换手术中种族和社会经济差异的影响
  • 批准号:
    10180776
  • 财政年份:
    2017
  • 资助金额:
    $ 35.76万
  • 项目类别:

相似海外基金

Planar culture of gastrointestinal stem cells for screening pharmaceuticals for adverse event risk
胃肠道干细胞平面培养用于筛选药物不良事件风险
  • 批准号:
    10707830
  • 财政年份:
    2023
  • 资助金额:
    $ 35.76万
  • 项目类别:
Hospital characteristics and Adverse event Rate Measurements (HARM) Evaluated over 21 years.
医院特征和不良事件发生率测量 (HARM) 经过 21 年的评估。
  • 批准号:
    479728
  • 财政年份:
    2023
  • 资助金额:
    $ 35.76万
  • 项目类别:
    Operating Grants
Analysis of ECOG-ACRIN adverse event data to optimize strategies for the longitudinal assessment of tolerability in the context of evolving cancer treatment paradigms (EVOLV)
分析 ECOG-ACRIN 不良事件数据,以优化在不断发展的癌症治疗范式 (EVOLV) 背景下纵向耐受性评估的策略
  • 批准号:
    10884567
  • 财政年份:
    2023
  • 资助金额:
    $ 35.76万
  • 项目类别:
AE2Vec: Medical concept embedding and time-series analysis for automated adverse event detection
AE2Vec:用于自动不良事件检测的医学概念嵌入和时间序列分析
  • 批准号:
    10751964
  • 财政年份:
    2023
  • 资助金额:
    $ 35.76万
  • 项目类别:
Understanding the real-world adverse event risks of novel biosimilar drugs
了解新型生物仿制药的现实不良事件风险
  • 批准号:
    486321
  • 财政年份:
    2022
  • 资助金额:
    $ 35.76万
  • 项目类别:
    Studentship Programs
Pediatric Adverse Event Risk Reduction for High Risk Medications in Children and Adolescents: Improving Pediatric Patient Safety in Dental Practices
降低儿童和青少年高风险药物的儿科不良事件风险:提高牙科诊所中儿科患者的安全
  • 批准号:
    10676786
  • 财政年份:
    2022
  • 资助金额:
    $ 35.76万
  • 项目类别:
Pediatric Adverse Event Risk Reduction for High Risk Medications in Children and Adolescents: Improving Pediatric Patient Safety in Dental Practices
降低儿童和青少年高风险药物的儿科不良事件风险:提高牙科诊所中儿科患者的安全
  • 批准号:
    10440970
  • 财政年份:
    2022
  • 资助金额:
    $ 35.76万
  • 项目类别:
Improving Adverse Event Reporting on Cooperative Oncology Group Trials
改进肿瘤学合作组试验的不良事件报告
  • 批准号:
    10642998
  • 财政年份:
    2022
  • 资助金额:
    $ 35.76万
  • 项目类别:
Planar culture of gastrointestinal stem cells for screening pharmaceuticals for adverse event risk
胃肠道干细胞平面培养用于筛选药物不良事件风险
  • 批准号:
    10482465
  • 财政年份:
    2022
  • 资助金额:
    $ 35.76万
  • 项目类别:
Expanding and Scaling Two-way Texting to Reduce Unnecessary Follow-Up and Improve Adverse Event Identification Among Voluntary Medical Male Circumcision Clients in the Republic of South Africa
扩大和扩大双向短信,以减少南非共和国自愿医疗男性包皮环切术客户中不必要的后续行动并改善不良事件识别
  • 批准号:
    10191053
  • 财政年份:
    2020
  • 资助金额:
    $ 35.76万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了